Author

B. Royer-Pokora

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:comparative / phylogenetic analysis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. D. Woods· 1 shared C. Keller· 1 shared G. Srivivasa· 1 shared J. E. Michalek· 1 shared K. E. Tranbarger Freier· 1 shared K. Matlock· 1 shared M. Beier· 1 shared M. Lathara· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. D. Woods

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early stem cell origin

B. Royer-Pokora, W. Wruck, M. Beier

bioRxiv · Jun 10, 2022Cancer Biology

Bromodomain 4 inhibition leads to MYCN downregulation in Wilms' tumor cells

A. D. Woods, C. Keller, N. E. Berlow, J. E. Michalek, B. Royer-Pokora, R. Purohit, K. E. Tranbarger Freier, M. Lathara, K. Matlock, G. Srivivasa, R. Veselska

This study shows that BRD4 inhibition reduces MYCN levels and suppresses proliferation in Wilms tumor cells, suggesting AZD5153 as a potential therapeutic agent.

bioRxiv · Jan 4, 2021 · PreprintCancer Biology